Theodorus
Overview
Theodorus is a venture capital firm investing in early-stage projects based on proprietary disruptive technologies. Dedicated to seed and early-stage funding, Theodorus focuses on biotech, medtech, digital, and engineering applications. The firm has priority access to Université libre de Bruxelles (ULB) R&D outcomes and spin-offs but also invests in projects outside ULB. Investment sizes range from €250,000 to €2.5 million per company. With over €70 million under management, Theodorus has closed four funds over the past 17 years, making it one of the most experienced spin-off funds in Belgium. As of the end of 2019, Theodorus had invested in 40 companies, leading to the creation of more than 600 jobs. The firm has a strong network of independent and international experts, advisors, and C-level advisors, and is committed to supporting the growth of innovative companies.
Investment Focus
- Professional and effective management team
- Proprietary and disruptive technologies
- Early investment stage (usually seed)
- Ambitious vision oriented towards international expansion
- High-level funding requirements, with Theodorus able to invest up to €2.5 million alongside other investors
Portfolio Companies
Reach Theodorus directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Theodorus
What sectors does Theodorus invest in?
Theodorus invests in Biotech, Medtech, Engineering and Digital, and is based in Brussels, Belgium. Theodorus is listed as a venture capital in the ConnectSafely investor database.
What stage does Theodorus invest at?
Theodorus backs companies at Seed and Early Stage, writing cheques of 250K - 2.5M.
Which regions does Theodorus invest in?
Theodorus invests across Canada and Belgium.
What companies has Theodorus invested in?
Theodorus's portfolio includes Ogeda, Euro Heat Pipes and MaSTherCell.
Last updated · Source: ConnectSafely investor database
